Vascular closure methods and apparatuses

Information

  • Patent Grant
  • 8048108
  • Patent Number
    8,048,108
  • Date Filed
    Wednesday, February 4, 2009
    15 years ago
  • Date Issued
    Tuesday, November 1, 2011
    12 years ago
Abstract
A vascular closure device comprised of a sheath-delivered expandable, umbrella-like device with structural radial members with terminal and non-terminal hooks that engage the vessel wall. Unlike other vascular closure umbrella-type devices that effect closure by opening of the umbrella to cover an opening, the present invention effects closure of the aperture with closure of the umbrella. The closure can be maintained by a retainer lock that slides down the members, causing contraction, bringing the members into a compressed configuration (e.g., a parallel orientation of linear members) and the wound edges together, permitting immediate vascular closure and healing of the blood vessel. The device can be delivered and recovered by an intravascular sheath.
Description
BACKGROUND

The present invention relates to methods and apparatuses for closing punctures and apertures in human and animal tissue and to methods and apparatuses for inserting such an apparatus into such tissue to perform such closure functions.


During angiography and related procedures, catheters are inserted through an incision or puncture in the skin and underlying tissues to access an artery or vein, typically in the groin, neck, or subclavian areas of a patient. The catheter can be inserted through a puncture in the blood vessel and guided to the desired site to perform interventional procedures such as angiography, angioplasty, plaque removal, and infusion of a therapeutic substance. After the procedure is completed and the catheter is removed from the patient, the access hole must be closed to prevent massive hemorrhage. This is conventionally achieved by applying pressure over the blood vessel manually and then by applying a pressure bandage, compressive weight, or clamp device. With conventional methods, the rate of post-puncture hemorrhage is high, which causes considerable complications. This complication is exacerbated by the concomitant use of anticoagulant medications such as heparin or warfarin and by antiplatelet drugs, which are commonly used to treat vascular disease.


Sutures have been used to close access puncture wounds in blood vessels. U.S. Pat. No. 05,613,974 describes a device and method for applying sutures to a vascular puncture. US2004/0093027A1 describes barbed suture-like material that apposes the puncture site. US 2005/0121042 A1 describes a device and method for applying suture to a vascular puncture. Difficulties with these methods include the large number of steps necessary to deploy the needles, capture the suture, withdraw the suture, tie the knot, and cut the suture. In addition, the hole in the blood vessel is often widened by insertion of the instrument, and the suture remains intravascularly on the endothelial surface, and thus can be a nidus for thrombus or intravascular mural hyperplasia with later spontaneous and catastrophic closure of the vessel.


Extravascular plugs have also been proposed for closure of vascular punctures. U.S. Pat. Nos. 05,254,105 and 05,330,445 describe an extravascular plug which is slid down the external surface of the catheter or introducer and is placed into the puncture site in this manner. U.S. Pat. No. 05,643,318 relates to a similar device that has its own vessel locator device. US22022822A1 and US2004/0158287A1 describe an extravascular plug that is delivered with a specialized system. US24215232A1 describes an extravascular plug with an intravascular anchor set with a sheath with a detection port. US2005/0085855A1 describes an extravascular collagen plug, held in place with an intravascular anchor, and a device that locks over a piece of suture.


U.S. Pat. No. 05,906,631 describes a plug made of hydrophilic material. U.S. Pat. No. 06,126,675 describes an intravascular anchor and a bioabsorble extravascular plug. U.S. Pat. No. 06,623,509 describes a bioabsorbable plug. U.S. Pat. Nos. 06,296,657 and 06,743,195 describe an inflatable balloon that puts pressure on the puncture site. U.S. Pat. No. 06,569, 185 describes an injectable vascular plug. U.S. Pat. No. 06,663,655 describes a plug that screws in the puncture tract. US2004/0143290 A1 describes a combination of an intraluminal balloon and injectable sealant. Disadvantages to these methods are related to the high likelihood of thrombosis associated with the intravascular plug or anchor, and the presence of collagen or other bioabsorble materials which cause inflammation, activate the clotting cascade, and increase the likelihood of thrombosis, which, in an arterial system, is catastrophic.


Vascular patches have also been used for repairing blood vessels, but usually only for large areas of damage. U.S. Pat. No. 05,100,422 describes a vascular patch that is sutured to the external surface of the damaged blood vessel. U.S. Pat. No. 05,100,422 describes a vascular patch achieved by instilled adhesives and the device for doing such. These are generally impractical for catheter-based methods. U.S. Pat. Nos. 06,248,124 and 05,507,744 describe devices and methods that use electrocautery for sealing vascular punctures. This also requires a complicated device, and perforation and thrombosis are very real possibilities.


Vascular clips or staples delivered through a catheter device have also been proposed. These devices have penetrating members that bring the edges of the tissue together. U.S. Pat. No. 06,695,867 describes a clip or staple that is delivered by a specialized device. U.S. Pat. No. 0,674,9622 describes a number of different clips with sharpened barbs or ends that include both intra- and extravascular portions, made of metal with memory characteristics. U.S. Pat. No. 05,861,005 describes an arterial staple that is delivered with a specialized device. U.S. Pat. No. 05,919,207 describes a stapling system based on long hooked wires that appose the surfaces, with a small staple gun to close the lesion. U.S. Pat. No. 06,022,372 describes a similar staple gun. U.S. Pat. Nos. 06,296,657, 06,663,655, and 06,749,621 describe a clip that is external to the vessel, but clips the two sides of the puncture together, and a device for achieving such. U.S. Pat. No. 5,782,861 and 5,964,782 describe clip devices composed of two or more prongs or hooks that, depending on the direction of the prongs, can clip together the puncture site from the intra- or extravascular position, through the use of a collar which forces the prongs together or other mechanisms. These clip devices are composed of thick semi-rigid material, and can be placed only with a specialized instruments, and because of the rigidity have great potential to injure or cut the blood vessel. Disadvantages of these clip devices in general include difficulty in retrieving the device if misplaced, excessive manipulation required, the thickness of the clip material which tends to cut or shear the blood vessel, the large forces that must be used to curve the staples and fix the clips, the increased possibility of tearing the blood vessel, and the general lack of control of the forces being applied to the blood vessel.


Accordingly, there is a need for methods and apparatuses that are suitable for closure of vascular punctures or other openings, and that do not suffer from the drawbacks of conventional approaches.


SUMMARY OF THE INVENTION

The present invention provides methods and apparatuses that are suitable for closure of vascular punctures or other openings, and that do not suffer from the drawbacks of conventional approaches.


The present invention comprises a tissue closure device, comprising a plurality of tissue engagement elements, mounted with each other such that in a first compressed configuration the tissue engagement elements can pass through a tissue opening to be closed, and such that in a second compressed configuration the tissue engagement elements bring the edges of the opening into apposition, and such that in an expanded configuration the tissue engagement elements span the opening, wherein the tissue engagement elements engage the tissue in the compressed configuration and in the expanded configuration.


The present invention also comprises methods for closing tissue openings, comprising passing a device while in the first compressed condition through a sheath that penetrates the proximal surface of the tissue; expelling the device from the sheath into space beyond the proximal surface of the tissue such that the device assumes the expanded configuration; c) manipulating the device such that the tissue engagement elements engage the tissue; d) causing the device to assume the second compressed configuration, bringing the edges of the opening into apposition.


The present invention can provide a catheter-delivered umbrella-like device comprising fine, strong, flexible material that after delivery expands in a blood vessel so that the individual members extend beyond the catheter edges and/or puncture dimensions. The device can be viewed as analagous in structure and design as contemporary expandable vascular filters and closure umbrellas, although its purpose and function is completely different. As the catheter is withdrawn, the device is pulled against the interior of the blood vessel and the hooks or grasping devices on the ends of the members seize the interior of the vessel wall. Because of the very fine and flexible nature of the members and their multiplicity, there is minimal shear force applied to the blood vessel. While pulling on the retaining suture to keep the device against the blood vessel, a retaining lock is then advanced distally starting at the proximal portion of the members, which causes the members to first angle the device into a conical shape and then force the individual members together in a linear parallel direction, which because the members are engaged with the vessel wall, brings the edges of the punctured tissue together into apposition. The retainer lock is then locked onto the parallel members and can keep tension on the wound externally, and can prevent intravascular migration of the device. If there is no blood leakage through the closure and the device is properly positioned and stable, then the guidewire can be removed and the retaining suture or string loop cut, resulting is complete and rapid closure, which can then heal.


Since this device brings the puncture edges together, there is true blood vessel healing with little endothelial disruption, reducing the chances of thrombosis or intimal hyperplasia. The device can be supplied in different diameters (e.g., french) to accommodate different sizes of catheters and different sizes of puncture holes.


The present invention can comprise a device with umbrella-like structure, which can be viewed as analogous to the various designs of intravascular filters and aperture seals, which are delivered in a folded or compressed form, and then expanded to their filter shapes. U.S. Pat. No. 4,969,891 describes a self-expanding removable filter device that is placed with a sheath. U.S. Pat. No. 5,634,942 and 5,634,942 describe a similar device but with two sets of arms which protrude in opposite directions. U.S. Pat. No. 6,241,746 B1 is a similar version that can be converted to a vascular stent. U.S. Pat. No. 6,361,546 is a version with a central guidewire lumen. U.S. Pat. No. 6,428,559 describes a variable-diameter vascular filter system. U.S. Pat. No. 6,485,501 B1 also describes a filter with a guidewire. US 2003/0208227 describes different construction configurations of a filter. US 2004/0087999 A1 reveals various types of structures to retain the filter in the vessel. U.S. Pat. No. 5,709,707 describes a typical umbrella-type closure device used to close apertures. Each of the preceding patents and applications are incorporated herein by reference. The present device, analogous to many of the vascular filters and umbrella closure devices noted above, is both expandable like an umbrella and retrievable if it had to be retrieved because of misplacement. Unlike previous umbrella closure devices, the present device engages the tissue in both the expanded and compressed configurations, and functions by bringing tissue edges into apposition rather than by providing a patch that covers the opening. In addition, although the embodiments shown here generally have linear members, these members, like the structure of the intravascular filters and umbrella-type devices, need not be strictly linear, but can assume a number of complex geometrical shapes and structural patterns.


The present device, like some contemporary vascular filters, can utilize an expanding material, preferably with memory characteristics, that opens up spontaneously within the blood vessel. The device also, like some contemporary filters, can have tissue hooks or penetrators, in order to seize the vessel wall and stabilize the device. However, unlike an umbrella-style vascular filter, the device uses this opening-dosing quality to seize the edges of the puncture site, and close them, resulting in a complete vascular closure. Although the device can be viewed as analogous to some contemporary self-expanding and retractable vascular filters, it is unlike them in that in certain embodiments it has a retaining lock to force the umbrella to reassume its folded state.





DESCRIPTION OF THE FIGURES

The invention is explained by using embodiment examples and corresponding drawings, which are incorporated into and form part of the specification.



FIG. 1(
a,b) is a schematic depiction of a vascular closure apposition device according to the present invention.



FIG. 2(
a,b) is a schematic depiction of a vascular closure apposition device according to the present invention.



FIG. 3(
a,b) is a schematic depiction of a vascular closure apposition device with a guidewire lumen, according to the present invention.



FIG. 4 is a schematic depiction of a vascular closure apposition device according to the present invention.



FIG. 5 is a schematic depiction of a vascular closure apposition device according to the present invention.



FIG. 6(
a,b,c) are schematic depictions of example embodiments of vascular closure apposition devices according to the present invention.



FIG. 7(
a,b,c,d,e,f) is a schematic illustration of a method of closing a vascular opening according to the present invention.


FIG. 8(a,b,c,d) is a schematic depiction of a double-action vascular closure apposition device according to the present invention.



FIG. 9(
a,b,c) is a schematic depiction of a double-action vascular closure apposition device according to the present invention.





DETAILED DESCRIPTION

The present invention provides apparatuses and methods for closing a vascular puncture wound or any tissue aperture, for example those resulting from the insertion of a vascular catheter or surgical instrument, trauma or disease. The present invention embraces both apparatus and method aspects of devices for closing a vascular puncture, and the methods for delivering such a device. The present device can be closed in the delivery system (catheter or sheath) and when discharged, be open in the blood vessel. In some embodiments, at least a portion of the device can be formed of a memory metal or similar material, as is currently done in vascular filters. The stress free state corresponds to the state at which the apparatus has opened in a blood vessel, and the stressed state in the catheter and when a retaining lock is put into position. Example embodiments of tissue closure apposition devices according to the present invention are shown in FIGS. 1, 2, 3, 4, 5, 6, and 8. The descriptions refer to “vessels” for convenience; the present invention is applicable to facilitate closure of various types of tissue openings.



FIG. 1 (a,b) is a lateral view of a vascular closure apposition umbrella. A plurality of members 101 are disposed substantially radially about a central junction 103. Each of the members 101 comprise a tissue hook 102, in the figure a double hook. The central junction 103 is adapted to engage a closed loop of string or suture 104. The hooks 102 engage the tissue, and are brought and maintained together by operation of a retaining lock 105. In FIG. 1b, the device is shown in a closed position, where the central junction 103 has passed through the retaining lock 105.


The vascular closure apposition umbrella of FIG. 1(a,b) comprises 2 or more members 101 placed in apposition to each other, shown in the figure as disposed substantially radially. The members 101 in the figure are shown as straight wires, but can be curved or have a wave structure or other design, for example a design to engage a retaining lock. The members are flexible for manipulation in tissue and delivery, yet rigid enough when extended to push the tissue engagement structures against the vessel wall. The tissue engagement structures 102 in this example comprise double hooks, allowing engagement of the tissue in 102 different directions simultaneously. The tissue engagement structures can also comprise multiple hooks, a single hook, or straight engaging devices. The tissue engagement structures can be sharp in order to penetrate in one direction, but not to cut, thus, would generally not have a cutting surface other than the point. The members join in a central junction 103 which can be continuous with each of the members or can be joined to the members by any suitable method. The central junction 103 comprises an eyelet or recovery loop in which initially a closed loop of string or suture 104 engages. The eyelet or recovery loop can be used to recover the device into a catheter in the event of misplacement. A retaining lock 105 can encourage closure of the device, and can also prevent unintended intravascular migration of the device. The retaining lock 105 is shown in the figure as a washer-like device, but can take a number of different shapes and can comprise a number of different materials. For example, the retaining lock 105 can comprise plastic; metal, or composite.


In operation, the tissue closure apposition umbrella is closed within the catheter or sheath, corresponding to the illustration of FIG. 1(b). Once placed within the blood vessel, the umbrella can be opened within the blood vessel, corresponding to the illustration of FIG. 1(a), so that the hooks on the members engage the vessel wall. The umbrella can then be closed with the retaining lock. As the umbrella closes with the retaining lock, the hooks hold the edges of the puncture wound and, as they align with each other, bring the puncture wound edges in apposition. Undulations or excresences on the members or central junction can engage corresponding locking surfaces on the retaining lock. More specific locking devices such as angled dentates, peg and hole, and male-female locking surfaces can also be suitable. A guidewire can go between the members in this particular embodiment without a specific lumen for the guidewire.



FIG. 2(
a,b) is a lateral view of a vascular closure apposition double umbrella. A plurality of members 201 are disposed substantially radially about a central junction 203. Each member comprises a tissue engagement structure 202, shown in the figure as a hook on the end of the member. The central junction can comprise a structure compatible with a string or suture 204 to facilitate deployment and removal. A retaining lock 205, in the figure an umbrella oriented opposite the umbrella formed by members 201, closes the device. FIG. 2(b) shows the device with the umbrella formed by members 201 closed, bringing tissue sides in apposition, and the retaining lock 205 open, maintaining the closed position of the umbrella and providing tissue stability on the opposite side of the vessel wall.


The radial members 201 in FIG. 2(a,b) are shown as straight, but can have dentates or other devices compatible with engagement of the retaining lock. The string or suture 204 can be engaged with the central junction 203 to urge the central junction 203 through the retaining lock 205, encouraging the members 201 into apposition. The retaining lock of the device of FIG. 2(a,b) comprises another expanding umbrella, but facing the opposite direction. In the figure, the retaining lock umbrella has straight members with hooks on the ends. The retaining lock umbrella can also comprise a variety of configurations, including bent or curved members, members with various hooks or no hooks, web-like structures, and film-like members. This retaining lock comprise more complicated structure members, as examples like many constructions of intravascular stents and filters. The members 201 close and bring the tissue together as in FIG. 2(b); the retaining lock can provide for tissue stability in the extravascular tissues. A guidewire in this embodiment can go between the members without a specific lumen for the guidewire.



FIG. 3(
a,b) is a lateral view of a vascular closure apposition umbrella with a guidewire lumen. The device comprises members 301 disposed substantially radially about a central junction 303. Each arm 301 comprises a tissue engagement structure 302, in the figure shown as a double hook on the end of the arm 301. The central junction 303 comprises a columnar guidewire lumen with a recovery loop or device for engaging a closed loop of string or suture 304. A retaining lock 305 that closes the device. FIG. 3(b) shows the device in a closed position with the retaining lock 305 engaged.


The embodiment of FIG. 3(a,b) comprises a closure apposition umbrella with a guidewire lumen. Inclusion of a guidewire lumen can reduce interference of the guidewire with placement of the umbrella, and allows the guidewire to remain in place in case the seating of the device is not optimal and then the device must be retrieved. The device can be delivered and placed with a guidewire in place. The apposed tissue might close the lumen once the guidewire is withdrawn. If desired, a soft one-way flap valve (not shown) or other structure can be placed in the lumen to occlude any blood flow that might occur when the wire is withdrawn.



FIG. 4 is a lateral view of a vascular closure apposition umbrella comprising members 401 disposed substantially radially about a central junction 403, forming an overall conical shape. The members have tissue engagement structures 402, shown in the figure as hooks at the ends of the members 401. The members also have reversed barbs or feathers 406 to prevent intravascular migration of the device and to maintain the members in a closed state by engaging the tissue, a retaining lock, or both. In operation, the embodiment of FIG. 4 is similar to those discussed previously.



FIG. 5 is a lateral view of a vascular closure apposition umbrella. A plurality of members 501 are disposed substantially radially about a central junction 503. The members have tissue engagement structures 502, shown in the figure as a hook at the end of the member 502. The central junction 503 can have a recovery loop or device, and can engage a string or suture 504 for delivery, placement, and recovery. A retaining lock 505 can engage the members 501, the central junction 503, or both, to encourage the device to and maintain the device in a closed position. A backing or coating 507 can be mounted with the members as a fabric, web, or film. The backing can carry, or be made of, a material that can elute drug to prevent coagulation or to prevent endothelial hyperplasia or can be hemostatic initially, and fill the puncture track later.



FIG. 6(
a,b,c) are lateral views of example embodiments of vascular closure apposition devices according to the present invention. In FIG. 6(a), members 601 comprise elongated diamond shapes (rather than the straight wires depicted previously), which shape can have advantages in manufacture and in operation. The members 601 have tissue engagement structures 602, in the figure shown as hooks mounted with members at various locations. In FIG. 6(b), a device having a reduced number of members 611 is shown. A reduced number of members can provide for a simpler device, which can have manufacturing advantages and can be suitable for certain applications. In FIG. 6(c), members 621 comprise a non-linear geometry, and are connected by intermember struts 628. The non-linear geometry and intermember struts can allow specific opening and closing trajectories, and can allow optimization of forces when opening and closing. A wide variety of specific geometries and structures can be suitable with the present invention, as examples including geometries and structures currently used in vascular filters and stents.



FIG. 7(
a,b,c,d,e,f) is a schematic illustration of a method of closing a vascular opening according to the present invention. A blood vessel 701 is penetrated by a sheath 702 and a guidewire 703. In FIG. 7(a), an apposition device 704, for example as described previously, is in a closed configuration within the sheath, with the loop of string or suture 705 engaged. In FIG. 7(b) the device 704 has been extruded from the sheath 702 and is in the expanded configuration within the vessel 701. In FIG. 7(c), the device 704 has been positioned against the wall of the vessel 701, seating the tissue engagement structures 706 in the tissue 701. The sheath 702 has been partially removed to facilitate seating of the device. The lock can be preseated on the device (not shown) or can be placed on the device after intravascular placement of the device by threading the lock down the guidewire or suture onto a central junction of the device after the device has been positioned in the blood vessel, or positioned by a separate sheath). In FIG. 7(d), a retaining lock 707 has been advanced over the members of the apposition device, forcing them into the closed configuration, and bringing the edges of the opening 709 together. If no bleeding occurs, then the guidewire 703 can be removed as shown in FIG. 7(e). The loop of string or suture 705 can be cut and removed, leaving the device 704 safely seated and locked with the opening closed, as shown in FIG. 7(f).


Delivery of the device can be done sequentially, or can be done with a dedicated device. For sequential delivery of the device, the following sequence of steps are suitable: 1) the guidewire and sheath are in place, 2) the device is pushed down the sheath, either next to the guidewire or with the guidewire in the lumen of the umbrella; 3) the umbrella is extruded, and then using the thread or suture, pulled tight against the lumen of the vessel; 4) the retaining lock is pushed down the thread and/or guidewire, and is pushed onto the umbrella while applying traction (the sheath can be removed partially at this stage); 5) after the retaining lock is seated, the sheath is observed for bleeding; 6) if there is no bleeding, then the sheath and guidewire are removed. For a dedicated device, there can be a sheath with the umbrella, a pushing device to push the umbrella out (another sheath), a sheath to push the retaining lock, and a thread/suture to oppose the other sheaths and to retrieve the umbrella if it is misplaced.



FIG. 8 (a,b,c,d) is a lateral view of a double-action vascular closure apposition device. In FIG. 8a, the unassembled device is in the closed position. The device comprises a plurality of umbrella members 801 disposed substantially radially about a central junction 803. Each umbrella member 801 can comprise a tissue hook 802, in the figure a double hook, spaced from the junction of the member and the central junction 803. The central junction 803 can include a central lumen for a guidewire, and is adapted to engage a plurality of opposite facing members 804, which opposite facing members can optionally have hooks, tissue penetrators, or feet. The opposite facing members can comprise memory material, and be configured such that they force a retaining lock 805 over the open umbrella members 1 (shown open in FIG. 8c) forcing them to close (as shown in FIG. 8d).


A closed loop of string or suture (not shown) can be joined to the device by ways of a lumen or loop. FIG. 8a shows the device preassembly. In FIG. 8b, the device is in assembled form and in a closed position, where the central junction 3 has passed through the retaining lock 805. In this form the double action vascular closure apposition device can reside within a delivery catheter before being placed in the puncture wound of a blood vessel. FIG. 8c shows the device partially expelled from the sheath (not shown), where the umbrella members 801 have opened and engaged the vessel wall, analogous to the embodiments previously described. In the arrangement of FIG. 8c, the opposite facing members 804 are retained in the sheath so that they are prevented from forcing the lock 805 over the umbrella members 801. FIG. 8d shows the device completely expelled from the delivery sheath, where the opposite facing members 804 are now forcing the retaining collar or lock 805 down the umbrella members 801, causing the portions of the umbrella members 801 with tissue engagement features (hooks in the figure) together (i.e., closing of the umbrella). The opposite facing members 804 are shown for ease of illustration as wire-like; they can be configured as coiled or semi-coiled structures, strut-like, multiple angles, spring-like, curled in an opposite direction, single or multiple members, elbow-like, or other geometrical or curvolinear shapes that when extended are neutral to the retaining lock, but when expelled, force the lock over the umbrella members, initiating closure.


Accordingly, the double action vascular closure apposition device of FIG. 8 is first closed, then opens, and then closes again, the second closure occurring spontaneously by contraction of the opposite facing members against the retaining lock. After the device has been delivered and vascular closure is complete, then the guidewire can be removed.



FIG. 9 (a,b,c,) is a lateral view of a collarless double-action vascular closure apposition device. FIG. 9a shows the device in the closed position. A plurality of umbrella members 901 are disposed substantially radially about a central junction 905, which can have a lumen for a guidewire. The central junction can comprise a retaining ring which permits the members to flex along their length. Each of the umbrella members 901 has a tissue engagement feature spaced apart from the central junction 905, in the figure a double hook 902. The central junction is adapted to engage a plurality of opposite facing members 903, which optionally can have hooks, tissue penetrators, or feet 904. The opposite facing members 904 can be composed of memory material, and can be directly joined to a corresponding umbrella member, with the memory forces in the opposite facing members dominant over the memory forces in the umbrella members. FIG. 9a depicts the form that the collarless double action vascular closure apposition device would have while within a delivery catheter before being placed in the puncture wound of the blood vessel.



FIG. 9
b shows the device partially expelled from the sheath (not shown). The umbrella members 901 have opened and engaged the vessel wall, analogous to embodiments described previously. The opposite members are still in the closed form, restrained there by the sheath. FIG. 9c shows the device completely expelled from the delivery sheath, where the opposite facing members 903 have curled or contracted. Since the opposite facing members are directly joined to the umbrella members and have dominant memory characteristics, they force the umbrella members 901 to close. The opposite facing members are shown in figure as wire-like for ease of illustration; they can be configured as coiled or semi-coiled structures, strut-like, multiple angles, spring-like, curled in an opposite direction, more than two members, elbow-like, or other geometrical or curvolinear shapes that when extended are neutral to the umbrella members, but when expelled, dominate over the umbrella members, and force closure of the umbrella members, initiating puncture wound closure.


Accordingly, the collarless double action vascular closure apposition device is first closed, then opens, and then closes again, with the second closure occurring spontaneously, by contraction of the opposite facing members which have dominant memory characteristics over the umbrella members. The central junction can be loose enough (e.g., made of a flexible polymer) to permit the forces from the contraction of the opposite facing members to be exerted on the umbrella members. In some embodiments each opposite facing member can be continuous with a corresponding umbrella member (i.e., a first portion of a single wire comprises an umbrella member, a second portion of the same wire comprising an opposite facing member). For simplicity, only two opposing members are shown in the figure; in embodiments where an umbrella member and a opposite facing member are formed from a single wire, the number of umbrella members can equal the number of opposite facing members, and each opposing member-umbrella member can be an integrated piece of memory material. After the device has been delivered and vascular closure is complete, then the guidewire can be removed.


In any of the embodiments described, the umbrella-like structure, members of this structure or components of the umbrella can be made from any number of suitable materials, including radioopaque materials and materials coated to be made radioopaque, including bioabsorbable polymers or compounds, non-absorbable alloys and compounds including stainless steel, MP35, Nitinol, Nickel-Titanium ally, Kevlar, nylon polyester acrylic, gold, platinum, tantalum, niobium, molybdenum, rhodium, palladium silver, hafnium, tungsten, iridium. Materials with memory would also be preferable to allow the umbrella to spontaneously open after placement by the sheath. These can be made in the form of wires, fibers, filaments, small beams, and other extruded, woven, or formed shapes. Piano wire, super elastic memory wire, chromium allows, alloys of titanium and nickel, and other elastic memory materials previously mentioned as well as others can be used as well The umbrella fabric can be made from a number of suitable materials, including flexible polymeric materials with elastomeric properties including polyurethane, polyethylene, polyestenurethane, polyimide, olyethreimide, polycarbonate, polysiloxane, polyvinyls, hydroxyethylmethacrylate, related polymers, co-polymers of these or other polymers, or drug-embedded or drug-eluting polymers to prevent coagulation or intimal hyperplasia (such as Taxol), also which can be made radioopaque by markers and addition of appropriate radiopaque materials.


EXAMPLE EMBODIMENTS

The present invention can comprise a device to close puncture wounds caused by catheter procedures and especially angiography comprised of an expandable umbrella-like device that in the compressed state resides in a sheath, and after being expelled from the sheath assumes a planar or conical or other shape, engages vessel wall by means of tissue hooks or penetrators, is collapsed, analogous to umbrella tines, and brings the edges of the vessel wound or puncture into apposition. The device can have a retaining locking device that prevents the umbrella-like structure from reopening. This locking can be achieved by mechanical means including deformable enlargements on the members, dentates, male-female connectors, peg and hole, or other directional mating/locking devices on the members and retaining locking device. This locking device can have a washer like appearance, but can also take a number of different forms, including an inverted umbrella device made of metal, plastic, composites, or biodegradable material.


The device can have single or multiple hooks and penetrating devices to engage and seize the vessel wall. Each hook can be a single or multiple hook. The device can have members (or tines) of the umbrella-like structure that are linear, curvilinear, spiral, leaf-like, diamond shaped, woven, or other complex shapes, but still function as an opening-closing structure that can accommodate a retaining lock. The device when expanded can have a planar or conical or reverse conical geometry, or other complex shape that can collapse into near-linear form with traction and locking of the retaining lock. The device can have a retrieval fitting, usually a loop, fitted with a closed loop thread, string, or suture in order to apply traction to the device. The device can have a lumen for a guidewire.


The device can have members that are coated or backed with a fabric or membrane, either completely or partially. The device can elute therapeutic material to prevent thrombogenesis, hemorrhage, inflammation, and intimal hyperplasia with vascular closure. The device can be used in angiography, angioplasty, vascular puncture, tissue biopsy, or trauma that cause a puncture wound that should be closed. The device can comprise materials with memory, so that the device spontaneously assumes it therapeutic shape when expelled from the sheath. The device can comprise at least 2 or more members; 3 or more members can be preferable in some applications. The device can have members with angled dentates or tissue penetrators to prevent movement or migration of the device into the lumen of the blood vessel. These can also be used to retain the retaining lock.


A tissue opening can be closed according to the present invention by a) introducing a guidewire and sheath, b) penetrating the proximal surface of the blood vessel by the sheath and the guidewire, c) placing a device in the closed form in the sheath, with the loop of string or suture, d) extruding the device from the sheath and expanding while in the tissue (e.g., while inside a blood vessel), e) pulling the device against the tissue wall (e.g., the blood vessel wall), seating the hooks in the tissue, f) partially removing the sheath is to seat the device while a retaining lock is advanced, g) advancing the retaining lock over the members of the device while applying traction with the string, forcing them in the closed position, h) bringing the edges of the puncture wound together; if no bleeding occurs, i) then removing the guidewire, j) cutting the loop of string, leaving the device safely seated and locked with the puncture repaired.


A tissue opening can be closed according to the present invention with sequential delivery of a device. For example, the following steps can be taken 1) first the guidewire and sheath are in place, 2) next the umbrella is pushed down the sheath, either next to the guidewire or with the guidewire in the lumen of the umbrella; 3) the umbrella is extruded, and then using the thread or suture, pulled tight against the lumen of the vessel; 4) next the retaining lock is pushed down the thread and/or guidewire, and is pushed onto the umbrella while applying traction (the sheath can be removed partially at this stage, 5) after the retaining lock is seated, the sheath is observed for bleeding, 6) if there is no bleeding, then the sheath and guidewire are removed.


A tissue opening can be closed according to the present invention employing a dedicated device consisting of a sheath containing a device, a pushing device to push the device out (e.g., another sheath), a sheath to push the retaining lock, and a thread/suture to oppose the movement of the other sheaths and to retrieve the umbrella if it is misplaced.


The particular sizes and equipment discussed above are cited merely to illustrate particular embodiments of the invention. It is contemplated that the use of the invention may involve components having different sizes and characteristics. It is intended that the scope of the invention be defined by the claims appended hereto.

Claims
  • 1. A method of closing an opening in tissue having a proximal surface using a device having a plurality of tissue engagement elements extending distally from a central junction and capable of occupying a plurality of compressed configurations and at least one expanded configuration and a separate locking element, said method comprising the steps of: passing the device while in a first one of the compressed configurations through a sheath disposed adjacent to an opening in the proximal surface of the tissue;expelling the device from the sheath into space beyond the proximal surface of the tissue such that the device assumes the at least one expanded configuration;manipulating the device such that the tissue engagement elements engage the tissue;following engaging the tissue with the tissue engagement elements, advancing the locking element along a flexible member from a proximal end of the flexible member toward the device and along the plurality of tissue engagement elements, the flexible member extending from a device proximal end at the central junction to a position remote from and proximal to the device proximal end; andmoving the device to bring edges of the opening into apposition.
  • 2. The method of claim 1, further comprising a step of maintaining the device in a second one of the compressed configurations after bringing the edges of the opening into apposition.
  • 3. The method of claim 2, wherein the second compressed configuration is expanded relative the first compressed configuration.
  • 4. The method of claim 3, wherein the at least one expanded configuration is expanded relative to the second compressed configuration.
  • 5. The method of claim 4, wherein the at least one expanded configuration defines a planar or conical shape.
  • 6. The method of claim 1, wherein the device includes a receiving element adapted to engage the flexible member and wherein said maintaining step comprises applying tensile force on the flexible member opposed to the force on the locking element to cause the device to occupy the second compressed configuration.
  • 7. The method of claim 1, wherein said moving step comprises applying traction to the device.
  • 8. The method of claim 7, wherein said manipulating step comprises pulling the flexible member to bias the device towards the tissue.
  • 9. The method of claim 8, wherein the moving step causes the device to occupy a second one of the compressed configurations.
  • 10. The method of claim 9, further comprising the steps of passing the flexible member through the locking element, passing the locking element down the flexible member to the device, pulling the flexible member such that a portion of the device engages the locking element and causes the device to assume the second compressed configuration.
  • 11. The method of claim 1, wherein the locking element defines a lumen and further comprising the step of passing a guidewire through the lumen.
  • 12. The method of claim 11, further comprising the step of observing the sheath for bleeding after the locking element is seated and then removing the sheath and guidewire if no bleeding is observed.
  • 13. The method of claim 1, wherein said manipulating step comprises pulling the flexible member coupled to the tissue engagement elements to bias the device towards the tissue.
  • 14. The method of claim 1, wherein the opening in tissue comprises an external opening in a blood vessel.
  • 15. The method of claim 14, wherein the opening comprises a vascular puncture wound.
  • 16. The method of claim 1, wherein said passing step comprises passing the device while in a first one of the compressed configurations through the sheath extending through the opening in the proximal surface of the tissue.
  • 17. A method of closing an opening in tissue having a proximal surface using a device having a plurality of tissue engagement elements extending distally from a central junction and capable of occupying a plurality of compressed configurations and at least one expanded configuration, each tissue engagement element include one or more tissue engagement structures, said method comprising the steps of: locating a sheath within the opening in the tissue, the sheath receiving a guidewire;passing the device while in a first one of the compressed configurations through a sheath disposed adjacent to an opening in the proximal surface of the tissue;expelling the device from the sheath into space beyond the proximal surface of the tissue such that the device assumes the at least one expanded configuration with the plurality of tissue engagement elements extending generally perpendicularly from the central junction of the device;with a flexible member extending proximally from the central junction of the device, manipulating the device to engage the tissue with the one or more tissue engagement structures of the tissue engagement elements; andfollowing engaging the tissue, advancing a locking element on the flexible member and along the plurality of tissue engagement element to move the device to bring edges of the opening into apposition.
  • 18. The method of claim 17, further comprising the step of passing the locking element along the guidewire to the device.
  • 19. The method of claim 17, further comprising the step of passing the locking element along the flexible member to the device.
  • 20. The method of claim 17, further comprising the step of maintaining the device in a second one of the compressed configurations after bringing the edges of the opening into apposition.
  • 21. The method of claim 20, wherein the second compressed configuration is expanded relative the first compressed configuration.
  • 22. The method of claim 17, wherein each tissue engagement element of the plurality of tissue engagement elements includes an angularly orientated tissue engagement structure and a tissue engagement structure extending generally perpendicularly from the tissue engagement element, the step of manipulating the device further comprises the step of engaging the angularly orientated tissue engagement structure and the tissue engagement structure into the tissue.
  • 23. The method of claim 17, wherein the step of advancing further comprising passing the locking element over the central junction.
  • 24. A method of closing an opening in tissue having a proximal surface using a device having a plurality of tissue engagement elements extending distally from a central junction and capable of occupying a plurality of compressed configurations and at least one expanded configuration and a separate locking element, each tissue engagement element include one or more tissue engagement structures, said method comprising the steps of: passing the device while in a first one of the compressed configurations through a sheath disposed adjacent to an opening in the proximal surface of the tissue;expelling the device from the sheath into space beyond the proximal surface of the tissue such that the device assumes the at least one expanded configuration with the plurality of tissue engagement element extending generally perpendicularly from the central junction of the device;with a flexible member extending proximally from the central junction of the device, manipulating the device to engage the tissue with the one or more tissue engagement structures of the tissue engagement elements; andfollowing engaging the tissue, advancing the locking element along a flexible member from a proximal portion of the flexible member toward the device, the flexible member extending from a device proximal end to a position remote from and proximal to the device proximal end; andmoving the locking member along the plurality of tissue engagement elements of the device to bring edges of the opening into apposition.
  • 25. The method of claim 24, further comprising a step of locating a guidewire and sheath in the opening of the tissue.
  • 26. The method of claim 25, further comprising removing the guidewire and sheath from the opening following opening closure.
  • 27. The method of claim 26, further comprising applying traction to the device while moving the locking member relative to the plurality of tissue engagement elements.
Parent Case Info

This application is a continuation of U.S. patent application Ser. No. 11/316,775 filed on Dec. 23, 2005, now abandoned, which is incorporated herein by reference, and which claims benefit of and priority to U.S. Provisional Patent Application No. 60/711,279, filed on Aug. 24, 2005.

US Referenced Citations (936)
Number Name Date Kind
287046 Norton Oct 1883 A
312408 Wackerhagen Feb 1885 A
438400 Brennen Oct 1890 A
597165 Hall Jan 1898 A
659422 Shidler Oct 1900 A
989231 Davis Apr 1911 A
1088393 Backus Feb 1914 A
1331401 Summers Feb 1920 A
1574362 Callahan Sep 1922 A
1596004 De Bengoa Aug 1926 A
1625602 Gould et al. Apr 1927 A
1647958 Ciarlante Nov 1927 A
1880569 Weis Oct 1932 A
1940351 Howard Mar 1933 A
2012776 Roeder Aug 1935 A
2087074 Tucker Jul 1937 A
2131321 Hart Oct 1937 A
2108206 Meeker Feb 1938 A
2127903 Bowen Aug 1938 A
2254620 Miller Sep 1941 A
2316297 Southerland et al. Apr 1943 A
2371978 Perham Mar 1945 A
2397823 Walter Apr 1946 A
RE22857 Ogburn Mar 1947 E
2453227 James Nov 1948 A
2595086 Larzelere Nov 1948 A
2583625 Bergan Jan 1952 A
2588589 Tauber Mar 1952 A
2610631 Calicchio Sep 1952 A
2646045 Priestley Jul 1953 A
2684070 Kelsey Jul 1954 A
2692599 Creelman Oct 1954 A
2910067 White Oct 1959 A
2941489 Fischbein Jun 1960 A
2944311 Schneckenberger Jul 1960 A
2951482 Sullivan Sep 1960 A
2959172 Held Nov 1960 A
2969887 Darmstadt et al. Jan 1961 A
3015403 Fuller Jan 1962 A
3033156 Verlish May 1962 A
3104666 Hale et al. Sep 1963 A
3113379 Frank Dec 1963 A
3120230 Skold Feb 1964 A
3142878 Santora Aug 1964 A
3197102 Bates et al. Jul 1965 A
3209754 Brown Oct 1965 A
3359983 Northey Dec 1967 A
3413397 Bierbaum et al. Nov 1968 A
3422181 Chirgwin, Jr. Jan 1969 A
3470875 Johnson Oct 1969 A
3482428 Kapitanov et al. Dec 1969 A
3494533 Green et al. Feb 1970 A
3523351 Filia Aug 1970 A
3586002 Wood Jun 1971 A
3587115 Shiley Jun 1971 A
3604425 Le Roy Sep 1971 A
3618447 Goins Nov 1971 A
3630205 Listner Dec 1971 A
3653388 Tenckhoff Apr 1972 A
3665926 Flores May 1972 A
3677243 Nerz Jul 1972 A
3757629 Schneider Sep 1973 A
3776237 Hill et al. Dec 1973 A
3802438 Wolvek Apr 1974 A
3805337 Branstetter Apr 1974 A
3814104 Irnich et al. Jun 1974 A
3820544 Semm Jun 1974 A
3828791 Santos Aug 1974 A
3840017 Violante Oct 1974 A
3856016 Davis Dec 1974 A
3874388 King et al. Apr 1975 A
3878848 Hiebert Apr 1975 A
3908662 Razgulov et al. Sep 1975 A
3918455 Coplan Nov 1975 A
3926194 Greenberg et al. Dec 1975 A
3939820 Grayzel Feb 1976 A
3944114 Coppens Mar 1976 A
3985138 Jarvik Oct 1976 A
4011872 Komiya Mar 1977 A
4014492 Rothfuss Mar 1977 A
4018228 Goosen Apr 1977 A
4064881 Meredith Dec 1977 A
4109658 Hughes Aug 1978 A
4128100 Wendorff Dec 1978 A
4135623 Thyen Jan 1979 A
4161951 Scanlan, Jr. Jul 1979 A
4162673 Patel Jul 1979 A
4168073 LaRue Sep 1979 A
4169476 Hiltebrandt Oct 1979 A
4182339 Hardy, Jr. Jan 1980 A
4185636 Gabbay et al. Jan 1980 A
4192315 Hilzinger et al. Mar 1980 A
4201215 Crossett et al. May 1980 A
4204541 Kapitanov May 1980 A
4207870 Eldridge Jun 1980 A
4214587 Sakura, Jr. Jul 1980 A
4215699 Patel Aug 1980 A
4216776 Downie et al. Aug 1980 A
4217665 Bex et al. Aug 1980 A
4217902 March Aug 1980 A
4235177 Arbuckle Nov 1980 A
4235238 Ogiu et al. Nov 1980 A
4278091 Borzone Jul 1981 A
4316469 Kapitanov Feb 1982 A
4317445 Robinson Mar 1982 A
4318401 Zimmerman Mar 1982 A
4327485 Rix May 1982 A
4345606 Littleford Aug 1982 A
4368736 Kaster Jan 1983 A
4396139 Hall et al. Aug 1983 A
4411654 Boarini et al. Oct 1983 A
4412832 Kling et al. Nov 1983 A
4428376 Mericle Jan 1984 A
4437465 Nomoto et al. Mar 1984 A
4440170 Golden et al. Apr 1984 A
4469101 Coleman et al. Sep 1984 A
4480356 Martin Nov 1984 A
4485816 Krumme Dec 1984 A
4492229 Grunwald Jan 1985 A
4493323 Albright et al. Jan 1985 A
4501276 Lombardi Feb 1985 A
RE31855 Osborne Mar 1985 E
4505273 Braun et al. Mar 1985 A
4505274 Speelman Mar 1985 A
4523695 Braun et al. Jun 1985 A
4525157 Vaillancourt Jun 1985 A
4526174 Froehlich Jul 1985 A
4553543 Amarasinghe Nov 1985 A
4586503 Kirsch et al. May 1986 A
4586614 Ger May 1986 A
4587969 Gillis May 1986 A
4592498 Braun et al. Jun 1986 A
4596559 Fleischhacker Jun 1986 A
4607638 Crainich Aug 1986 A
4610248 Rosenberg Sep 1986 A
4610251 Kumar Sep 1986 A
4610252 Catalano Sep 1986 A
4629450 Suzuki et al. Dec 1986 A
4635634 Santos Jan 1987 A
4651733 Mobin-Uddin Mar 1987 A
4655211 Sakamoto et al. Apr 1987 A
4665906 Jervis May 1987 A
4687469 Osypka Aug 1987 A
4693249 Schenck et al. Sep 1987 A
4702250 Ovil et al. Oct 1987 A
4719917 Barrows et al. Jan 1988 A
4723549 Wholey et al. Feb 1988 A
4724840 McVay et al. Feb 1988 A
4738658 Magro et al. Apr 1988 A
4738666 Fuqua Apr 1988 A
4744364 Kensey May 1988 A
4747407 Liu et al. May 1988 A
4748982 Horzewski et al. Jun 1988 A
4759364 Boebel Jul 1988 A
4771782 Millar Sep 1988 A
4772266 Groshong Sep 1988 A
4777950 Kees, Jr. Oct 1988 A
4789090 Blake, III Dec 1988 A
4803984 Narayanan et al. Feb 1989 A
4830002 Semm May 1989 A
4832688 Sagae et al. May 1989 A
4836204 Landymore et al. Jun 1989 A
4836205 Barrett Jun 1989 A
4848341 Ahmad Jul 1989 A
4852568 Kensey Aug 1989 A
4860746 Yoon Aug 1989 A
4865026 Barrett Sep 1989 A
4874122 Froelich et al. Oct 1989 A
4878915 Brantigan Nov 1989 A
4887601 Richards Dec 1989 A
4890612 Kensey Jan 1990 A
4898155 Ovil et al. Feb 1990 A
4902508 Badylak et al. Feb 1990 A
4911164 Roth Mar 1990 A
4917087 Walsh et al. Apr 1990 A
4917089 Sideris Apr 1990 A
4926860 Stice et al. May 1990 A
4929240 Kirsch et al. May 1990 A
4929246 Sinofsky May 1990 A
4934364 Green Jun 1990 A
4935027 Yoon Jun 1990 A
4950258 Kawai et al. Aug 1990 A
4950285 Wilk Aug 1990 A
4957498 Caspari et al. Sep 1990 A
4957499 Lipatov et al. Sep 1990 A
4961729 Vaillancourt Oct 1990 A
4966600 Songer et al. Oct 1990 A
4981149 Yoon et al. Jan 1991 A
4983168 Moorehead Jan 1991 A
4984581 Stice Jan 1991 A
4997436 Oberlander Mar 1991 A
4997439 Chen Mar 1991 A
5002562 Oberlander Mar 1991 A
5002563 Pyka et al. Mar 1991 A
5007921 Brown Apr 1991 A
5009643 Reich et al. Apr 1991 A
5015247 Michelson May 1991 A
5021059 Kensey et al. Jun 1991 A
5026390 Brown Jun 1991 A
5030226 Green et al. Jul 1991 A
5032127 Frazee et al. Jul 1991 A
5037433 Wilk et al. Aug 1991 A
5041129 Hayhurst et al. Aug 1991 A
5047039 Avant et al. Sep 1991 A
5047047 Yoon Sep 1991 A
5053008 Bajaj Oct 1991 A
5059201 Asnis Oct 1991 A
5061274 Kensey Oct 1991 A
5074874 Yoon et al. Dec 1991 A
5078721 McKeating Jan 1992 A
5078731 Hayhurst Jan 1992 A
5080664 Jain Jan 1992 A
5092941 Miura Mar 1992 A
5100418 Yoon et al. Mar 1992 A
5100419 Ehlers Mar 1992 A
5100422 Berguer et al. Mar 1992 A
5100432 Matsutani Mar 1992 A
5108420 Marks Apr 1992 A
5108421 Fowler Apr 1992 A
5109780 Slouf et al. May 1992 A
5114032 Laidlaw May 1992 A
5114065 Storace May 1992 A
5116349 Aranyi May 1992 A
5122122 Allgood Jun 1992 A
5122156 Granger et al. Jun 1992 A
5129882 Weldon et al. Jul 1992 A
5129912 Noda et al. Jul 1992 A
5129913 Ruppert Jul 1992 A
5131379 Sewell, Jr. Jul 1992 A
5144961 Chen et al. Sep 1992 A
5147373 Ferzli Sep 1992 A
5147381 Heimerl et al. Sep 1992 A
5156609 Nakao et al. Oct 1992 A
5156788 Chesterfield et al. Oct 1992 A
5160339 Chen et al. Nov 1992 A
5163946 Li Nov 1992 A
5167634 Corrigan, Jr. et al. Dec 1992 A
5167643 Lynn Dec 1992 A
5171249 Stefanchik et al. Dec 1992 A
5171250 Yoon Dec 1992 A
5171251 Bregen et al. Dec 1992 A
5176648 Holmes et al. Jan 1993 A
5176691 Pierce Jan 1993 A
5178629 Kammerer Jan 1993 A
5192287 Fournier et al. Mar 1993 A
5192288 Thompson et al. Mar 1993 A
5192294 Blake, III Mar 1993 A
5192300 Fowler Mar 1993 A
5192301 Kamiya et al. Mar 1993 A
5192302 Kensey et al. Mar 1993 A
5192602 Spencer et al. Mar 1993 A
5201744 Jones Apr 1993 A
5207703 Jain May 1993 A
5209756 Seedhom et al. May 1993 A
5211650 Noda May 1993 A
5217024 Dorsey et al. Jun 1993 A
5217470 Weston Jun 1993 A
5217471 Burkhart Jun 1993 A
5217485 Liv et al. Jun 1993 A
5219358 Bendel et al. Jun 1993 A
5222974 Kensey et al. Jun 1993 A
5226908 Yoon Jul 1993 A
5234443 Phan et al. Aug 1993 A
5234445 Walker et al. Aug 1993 A
5236435 Sewell, Jr. Aug 1993 A
5237996 Waldman Aug 1993 A
5242427 Bilweis Sep 1993 A
5242457 Akopov et al. Sep 1993 A
5242459 Buelna Sep 1993 A
5243857 Velez Sep 1993 A
5246156 Rothfuss et al. Sep 1993 A
5246443 Mai Sep 1993 A
5250033 Evans et al. Oct 1993 A
5250053 Snyder Oct 1993 A
5250054 Li Oct 1993 A
5250058 Miller et al. Oct 1993 A
5254105 Haaga Oct 1993 A
5254113 Wilk Oct 1993 A
5254126 Filipi et al. Oct 1993 A
5258003 Ciaglia et al. Nov 1993 A
5259846 Granger et al. Nov 1993 A
5269792 Kovac et al. Dec 1993 A
5275616 Fowler Jan 1994 A
5279311 Snyder Jan 1994 A
5281236 Bognato et al. Jan 1994 A
5281237 Gimpelson Jan 1994 A
5281422 Badylak et al. Jan 1994 A
5282808 Kovac et al. Feb 1994 A
5282827 Kensey et al. Feb 1994 A
5284485 Kammerer et al. Feb 1994 A
5285945 Brinkerhoff et al. Feb 1994 A
5289963 McGarry et al. Mar 1994 A
5290243 Chodorow et al. Mar 1994 A
5290284 Adair Mar 1994 A
5290297 Phillips Mar 1994 A
5290310 Makower et al. Mar 1994 A
5292309 Van Tassel et al. Mar 1994 A
5292327 Dodd et al. Mar 1994 A
5292332 Lee Mar 1994 A
5293881 Green et al. Mar 1994 A
5295993 Green Mar 1994 A
5300085 Yock Apr 1994 A
5304184 Hathaway et al. Apr 1994 A
5304185 Taylor Apr 1994 A
5304204 Bregen Apr 1994 A
5306254 Nash et al. Apr 1994 A
5312024 Grant et al. May 1994 A
5312423 Rosenbluth et al. May 1994 A
5318542 Hirsch et al. Jun 1994 A
5318578 Hasson Jun 1994 A
5320629 Noda et al. Jun 1994 A
5320632 Heidmueller Jun 1994 A
5320639 Rudnick Jun 1994 A
5330445 Haaga Jul 1994 A
5330491 Walker et al. Jul 1994 A
5334216 Vidal et al. Aug 1994 A
5334217 Das Aug 1994 A
5335680 Moore Aug 1994 A
5336229 Noda Aug 1994 A
5336230 Leichtling et al. Aug 1994 A
5336231 Adair Aug 1994 A
5340360 Stefanchik Aug 1994 A
5342369 Harryman, II Aug 1994 A
5350399 Erlebacher et al. Sep 1994 A
5352229 Goble et al. Oct 1994 A
5354279 Hofling Oct 1994 A
5354312 Brinkerhoff et al. Oct 1994 A
5364406 Sewell, Jr. Nov 1994 A
5364407 Poll Nov 1994 A
5364408 Gordon Nov 1994 A
5366458 Korthoff et al. Nov 1994 A
5366479 McGarry et al. Nov 1994 A
5368595 Lewis Nov 1994 A
5368601 Sauer et al. Nov 1994 A
5374275 Bradley et al. Dec 1994 A
5374278 Chesterfield et al. Dec 1994 A
5376096 Foster Dec 1994 A
5383896 Gershony et al. Jan 1995 A
5383905 Golds et al. Jan 1995 A
5385569 Swor Jan 1995 A
RE34866 Kensey et al. Feb 1995 E
5387221 Bisgaard Feb 1995 A
5387227 Grice Feb 1995 A
5391176 de la Torre Feb 1995 A
5391182 Chin Feb 1995 A
5392978 Velez et al. Feb 1995 A
5395030 Kuramoto et al. Mar 1995 A
5395332 Ressemann et al. Mar 1995 A
5395349 Quiachon et al. Mar 1995 A
5397310 Chu et al. Mar 1995 A
5397325 Della Badia et al. Mar 1995 A
5397326 Mangum Mar 1995 A
5403329 Hinchcliffe Apr 1995 A
5403330 Tuason Apr 1995 A
5403331 Chesterfield et al. Apr 1995 A
5403338 Milo Apr 1995 A
5411481 Allen et al. May 1995 A
5411520 Nash et al. May 1995 A
5413571 Katsaros et al. May 1995 A
5413584 Schulze May 1995 A
5416584 Kay May 1995 A
5417699 Klein et al. May 1995 A
5419765 Weldon et al. May 1995 A
5419777 Hofling May 1995 A
5423857 Rosenman et al. Jun 1995 A
5425489 Shichman et al. Jun 1995 A
5425705 Evard et al. Jun 1995 A
5425740 Hutchinson, Jr. Jun 1995 A
5431639 Shaw Jul 1995 A
5431666 Sauer et al. Jul 1995 A
5431667 Thompson et al. Jul 1995 A
5433700 Peters Jul 1995 A
5433721 Hooven et al. Jul 1995 A
5437631 Janzen Aug 1995 A
5439479 Shichman et al. Aug 1995 A
5443477 Marin et al. Aug 1995 A
5443481 Lee Aug 1995 A
5449359 Groiso Sep 1995 A
5452733 Sterman et al. Sep 1995 A
5454822 Schob et al. Oct 1995 A
5454834 Boebel et al. Oct 1995 A
5456400 Shichman et al. Oct 1995 A
5458574 Machold et al. Oct 1995 A
5462560 Stevens Oct 1995 A
5462561 Voda Oct 1995 A
5464426 Bonutti Nov 1995 A
5466241 Leroy et al. Nov 1995 A
5470010 Rothfuss et al. Nov 1995 A
5470338 Whitfield et al. Nov 1995 A
5474557 Mai Dec 1995 A
5476469 Hathaway et al. Dec 1995 A
5476470 Fitzgibbons, Jr. Dec 1995 A
5478309 Sweezer et al. Dec 1995 A
5478352 Fowler Dec 1995 A
5478353 Yoon Dec 1995 A
5478354 Tovey et al. Dec 1995 A
5480407 Wan et al. Jan 1996 A
5486190 Green Jan 1996 A
5486195 Myers et al. Jan 1996 A
5489295 Piplani et al. Feb 1996 A
5492119 Abrams Feb 1996 A
5496332 Sierra et al. Mar 1996 A
5497933 DeFonzo et al. Mar 1996 A
5507744 Tay et al. Apr 1996 A
5507755 Gresl et al. Apr 1996 A
5507757 Sauer et al. Apr 1996 A
5507758 Thomason et al. Apr 1996 A
5509902 Raulerson Apr 1996 A
5520655 Davila et al. May 1996 A
5520665 Fleetwood May 1996 A
5520702 Sauer et al. May 1996 A
5522840 Krajicek Jun 1996 A
5527321 Hinchliffe Jun 1996 A
5527322 Klein et al. Jun 1996 A
D372310 Hartnett Jul 1996 S
5531700 Moore et al. Jul 1996 A
5536251 Evard et al. Jul 1996 A
5536267 Edwards Jul 1996 A
5536273 Lehrer Jul 1996 A
5540701 Sharkey et al. Jul 1996 A
5540704 Gordon et al. Jul 1996 A
5540712 Kleshinski et al. Jul 1996 A
5540716 Hlavacek Jul 1996 A
5544802 Crainich Aug 1996 A
5545171 Sharkey et al. Aug 1996 A
5545178 Kensey et al. Aug 1996 A
5545180 Le et al. Aug 1996 A
5547474 Kloeckl et al. Aug 1996 A
5549618 Fleenor et al. Aug 1996 A
5549631 Bonutti Aug 1996 A
5554162 DeLange Sep 1996 A
5560532 DeFonzo et al. Oct 1996 A
5562684 Kammerer Oct 1996 A
5562686 Sauer et al. Oct 1996 A
5562688 Riza Oct 1996 A
5562728 Lazarus et al. Oct 1996 A
5567435 Hubbell et al. Oct 1996 A
5569269 Hart et al. Oct 1996 A
5569271 Hoel Oct 1996 A
5571120 Yoon Nov 1996 A
5573540 Yoon Nov 1996 A
5573784 Badylak et al. Nov 1996 A
5575771 Walinsky Nov 1996 A
5584842 Fogarty et al. Dec 1996 A
5584879 Reimold et al. Dec 1996 A
5591177 Lehrer Jan 1997 A
5591179 Edelstein Jan 1997 A
5591205 Fowler Jan 1997 A
5591206 Moufarrege Jan 1997 A
5593412 Martinez et al. Jan 1997 A
5593421 Bauer Jan 1997 A
5601602 Fowler Feb 1997 A
5603718 Xu Feb 1997 A
5607435 Sachdeva et al. Mar 1997 A
5609597 Lehrer Mar 1997 A
5611794 Sauer et al. Mar 1997 A
5613974 Andreas et al. Mar 1997 A
5613975 Christy Mar 1997 A
5618291 Thompson et al. Apr 1997 A
5620452 Yoon Apr 1997 A
5620461 Muijs et al. Apr 1997 A
5624446 Harryman, II Apr 1997 A
5626588 Sauer et al. May 1997 A
5643289 Sauer et al. Jul 1997 A
5643295 Yoon Jul 1997 A
5643318 Tsukernik et al. Jul 1997 A
5645565 Rudd et al. Jul 1997 A
5645566 Brenneman et al. Jul 1997 A
5645567 Crainich Jul 1997 A
5647372 Tovey et al. Jul 1997 A
5649959 Hannam et al. Jul 1997 A
D383539 Croley Sep 1997 S
5662664 Gordon et al. Sep 1997 A
5669917 Sauer et al. Sep 1997 A
5672174 Gough et al. Sep 1997 A
5674231 Green et al. Oct 1997 A
5676689 Kensey et al. Oct 1997 A
5676974 Valdes et al. Oct 1997 A
5681334 Evans et al. Oct 1997 A
5683405 Yacoubian et al. Nov 1997 A
5690674 Diaz Nov 1997 A
5693061 Pierce et al. Dec 1997 A
5695504 Gifford, III et al. Dec 1997 A
5695505 Yoon Dec 1997 A
5695524 Kelley et al. Dec 1997 A
5700273 Buelna et al. Dec 1997 A
5707379 Fleenor et al. Jan 1998 A
5713899 Marnay et al. Feb 1998 A
5713910 Gordon et al. Feb 1998 A
5716369 Riza Feb 1998 A
5716375 Fowler Feb 1998 A
5720574 Barella Feb 1998 A
5720755 Dakov Feb 1998 A
5720757 Hathaway et al. Feb 1998 A
5722981 Stevens Mar 1998 A
5725498 Janzen et al. Mar 1998 A
5725552 Kotula et al. Mar 1998 A
5725554 Simon et al. Mar 1998 A
5728109 Schulze et al. Mar 1998 A
5728110 Vidal et al. Mar 1998 A
5728114 Evans et al. Mar 1998 A
5728122 Leschinsky et al. Mar 1998 A
5728132 Van Tassel et al. Mar 1998 A
5728133 Kontos Mar 1998 A
5728143 Gough et al. Mar 1998 A
5728151 Garrison et al. Mar 1998 A
5732872 Bolduc et al. Mar 1998 A
5735873 MacLean Apr 1998 A
5741276 Poloyko et al. Apr 1998 A
5741280 Fleenor Apr 1998 A
5746755 Wood et al. May 1998 A
5749890 Shaknovich May 1998 A
5752966 Chang May 1998 A
5755726 Pratt et al. May 1998 A
5755727 Kontos May 1998 A
5755778 Kleshinski May 1998 A
5759188 Yoon Jun 1998 A
5759189 Ferragamo et al. Jun 1998 A
5766183 Sauer Jun 1998 A
5766186 Faraz et al. Jun 1998 A
5766217 Christy Jun 1998 A
5766246 Mulhauser et al. Jun 1998 A
5769862 Kammerer et al. Jun 1998 A
5769870 Salahieh et al. Jun 1998 A
5779707 Bertholet et al. Jul 1998 A
5779719 Klein et al. Jul 1998 A
5782844 Yoon et al. Jul 1998 A
5782860 Epstein et al. Jul 1998 A
5782861 Cragg et al. Jul 1998 A
5792151 Heck et al. Aug 1998 A
5792152 Klein et al. Aug 1998 A
5795958 Rao et al. Aug 1998 A
5797928 Kogasaka Aug 1998 A
5797929 Andreas et al. Aug 1998 A
5797931 Bito et al. Aug 1998 A
5797933 Snow et al. Aug 1998 A
5797958 Yoon Aug 1998 A
5799661 Boyd et al. Sep 1998 A
5810776 Bacich et al. Sep 1998 A
5810846 Virnich et al. Sep 1998 A
5810849 Kontos Sep 1998 A
5810850 Hathaway et al. Sep 1998 A
5810851 Yoon Sep 1998 A
5817113 Gifford et al. Oct 1998 A
5820631 Nobles Oct 1998 A
5824010 McDonald Oct 1998 A
5824111 Schall et al. Oct 1998 A
5827298 Hart et al. Oct 1998 A
5830125 Scribner et al. Nov 1998 A
5833698 Hinchliffe et al. Nov 1998 A
5836955 Buelna et al. Nov 1998 A
5836956 Buelna et al. Nov 1998 A
5843167 Dwyer et al. Dec 1998 A
5846253 Buelna et al. Dec 1998 A
5848714 Robson et al. Dec 1998 A
5853421 Leschinsky et al. Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5855312 Toledano Jan 1999 A
5855576 LeVeen et al. Jan 1999 A
5855585 Kontos Jan 1999 A
5858082 Cruz et al. Jan 1999 A
5860963 Azam et al. Jan 1999 A
5860990 Nobles et al. Jan 1999 A
5860991 Klein et al. Jan 1999 A
5861005 Kontos Jan 1999 A
5868755 Kanner et al. Feb 1999 A
5868763 Spence et al. Feb 1999 A
5871474 Hermann et al. Feb 1999 A
5871490 Schulze et al. Feb 1999 A
5871501 Leschinsky et al. Feb 1999 A
5871502 Suryadevara Feb 1999 A
5871525 Edwards et al. Feb 1999 A
5873876 Christy Feb 1999 A
5876411 Kontos Mar 1999 A
5879366 Shaw et al. Mar 1999 A
5891088 Thompson et al. Apr 1999 A
5897487 Ouchi Apr 1999 A
5897564 Schulze et al. Apr 1999 A
5902310 Foerster et al. May 1999 A
5902311 Andreas et al. May 1999 A
5904597 Doi et al. May 1999 A
5904690 Middleman et al. May 1999 A
5904697 Gifford, III et al. May 1999 A
5906631 Imran May 1999 A
5907893 Zadno-Azizi et al. Jun 1999 A
5910155 Ratcliff et al. Jun 1999 A
5919207 Taheri Jul 1999 A
5921994 Andreas et al. Jul 1999 A
5922009 Epstein et al. Jul 1999 A
5928266 Kontos Jul 1999 A
5935147 Kensey et al. Aug 1999 A
5938667 Peyser et al. Aug 1999 A
5941890 Voegele et al. Aug 1999 A
5947999 Groiso Sep 1999 A
5951518 Licata et al. Sep 1999 A
5951547 Gough et al. Sep 1999 A
5951576 Wakabayashi Sep 1999 A
5951589 Epstein et al. Sep 1999 A
5951590 Goldfarb Sep 1999 A
5954732 Hart et al. Sep 1999 A
5957936 Yoon et al. Sep 1999 A
5957937 Yoon Sep 1999 A
5957938 Zhu et al. Sep 1999 A
5964773 Greenstein Oct 1999 A
5964782 Lafontaine et al. Oct 1999 A
5972009 Fortier et al. Oct 1999 A
5972030 Garrison et al. Oct 1999 A
5976161 Kirsch et al. Nov 1999 A
5980517 Gough et al. Nov 1999 A
5980539 Kontos Nov 1999 A
5984934 Ashby et al. Nov 1999 A
5984949 Levin Nov 1999 A
5984950 Cragg et al. Nov 1999 A
5993466 Yoon Nov 1999 A
5993468 Rygaard Nov 1999 A
5993476 Groiso Nov 1999 A
5997555 Kontos Dec 1999 A
6001109 Kontos Dec 1999 A
6001110 Adams Dec 1999 A
6004341 Zhu et al. Dec 1999 A
6007563 Nash et al. Dec 1999 A
6009877 Edwards Jan 2000 A
6010517 Baccaro Jan 2000 A
6013084 Ken et al. Jan 2000 A
6015815 Mollison Jan 2000 A
6022372 Kontos Feb 2000 A
6024747 Kontos Feb 2000 A
6024750 Mastri et al. Feb 2000 A
6030364 Durgin et al. Feb 2000 A
6030413 Lazarus Feb 2000 A
6033427 Lee Mar 2000 A
6036699 Andreas et al. Mar 2000 A
6036703 Evans et al. Mar 2000 A
6036720 Abrams et al. Mar 2000 A
6042601 Smith Mar 2000 A
6045570 Epstein et al. Apr 2000 A
6048351 Gordon et al. Apr 2000 A
6048354 Lawrence Apr 2000 A
6048357 Kontos Apr 2000 A
6048358 Barak Apr 2000 A
6056744 Edwards May 2000 A
6056768 Cates et al. May 2000 A
6056769 Epstein et al. May 2000 A
6056770 Epstein et al. May 2000 A
6059800 Hart et al. May 2000 A
6059825 Hobbs et al. May 2000 A
6063085 Tay et al. May 2000 A
6063114 Nash et al. May 2000 A
6068603 Suzuki May 2000 A
6071300 Brenneman et al. Jun 2000 A
6077276 Kontos Jun 2000 A
6077279 Kontos Jun 2000 A
6077281 Das Jun 2000 A
6077291 Das Jun 2000 A
6080182 Shaw et al. Jun 2000 A
6080183 Tsugita et al. Jun 2000 A
6083242 Cook Jul 2000 A
6090130 Nash et al. Jul 2000 A
6102271 Longo et al. Aug 2000 A
6110184 Weadock Aug 2000 A
6113612 Swanson et al. Sep 2000 A
6117125 Rothbarth et al. Sep 2000 A
6117144 Nobles et al. Sep 2000 A
6117145 Wood et al. Sep 2000 A
6117148 Ravo Sep 2000 A
6117157 Tekulve Sep 2000 A
6120524 Taheri Sep 2000 A
6126675 Shchervinsky et al. Oct 2000 A
6132439 Kontos Oct 2000 A
6132440 Hathaway et al. Oct 2000 A
6136010 Modesitt et al. Oct 2000 A
6139556 Kontos Oct 2000 A
6143004 Davis Nov 2000 A
6149660 Laufer et al. Nov 2000 A
6149667 Hovland et al. Nov 2000 A
6152144 Lesh et al. Nov 2000 A
6152936 Christy et al. Nov 2000 A
6152937 Peterson et al. Nov 2000 A
6165204 Levinson et al. Dec 2000 A
6171277 Ponzi Jan 2001 B1
6171329 Shaw et al. Jan 2001 B1
6190396 Whitin et al. Feb 2001 B1
6193708 Ken et al. Feb 2001 B1
6193734 Bolduc et al. Feb 2001 B1
6197042 Ginn et al. Mar 2001 B1
6198974 Webster, Jr. Mar 2001 B1
6200329 Fung et al. Mar 2001 B1
6206893 Klein et al. Mar 2001 B1
6206913 Yencho et al. Mar 2001 B1
6206931 Cook et al. Mar 2001 B1
6210407 Webster Apr 2001 B1
6220248 Voegele et al. Apr 2001 B1
6221084 Fleenor Apr 2001 B1
6221102 Baker et al. Apr 2001 B1
6245079 Nobles et al. Jun 2001 B1
6248124 Pedros et al. Jun 2001 B1
6254617 Spence et al. Jul 2001 B1
6254642 Taylor Jul 2001 B1
6276704 Suiter Aug 2001 B1
6277140 Ginn et al. Aug 2001 B2
6280460 Bolduc et al. Aug 2001 B1
6287322 Zhu et al. Sep 2001 B1
6296657 Brucker Oct 2001 B1
6305891 Burlingame Oct 2001 B1
6306081 Ishikawa et al. Oct 2001 B1
6319258 McAllen, III et al. Nov 2001 B1
6322580 Kanner Nov 2001 B1
6328727 Frazier et al. Dec 2001 B1
6329386 Mollison Dec 2001 B1
6334865 Redmond et al. Jan 2002 B1
6348059 Hathaway et al. Feb 2002 B1
6348064 Kanner Feb 2002 B1
6355050 Andreas et al. Mar 2002 B1
6358258 Arcia et al. Mar 2002 B1
6375671 Kobayashi et al. Apr 2002 B1
D457958 Dycus May 2002 S
6383208 Sancoff et al. May 2002 B1
6391048 Ginn et al. May 2002 B1
6395015 Borst et al. May 2002 B1
6397110 Kuzma May 2002 B1
6398752 Sweezer et al. Jun 2002 B1
6402765 Monassevitch et al. Jun 2002 B1
6409739 Nobles et al. Jun 2002 B1
6419669 Frazier et al. Jul 2002 B1
6423054 Ouchi Jul 2002 B1
6425911 Akerfeldt et al. Jul 2002 B1
6428472 Haas Aug 2002 B1
6428548 Durgin et al. Aug 2002 B1
6428549 Kontos Aug 2002 B1
6436109 Kontos Aug 2002 B1
6443158 Lafontaine et al. Sep 2002 B1
6443963 Baldwin et al. Sep 2002 B1
6447540 Fontaine et al. Sep 2002 B1
6450391 Kayan et al. Sep 2002 B1
6451031 Kontos Sep 2002 B1
6458130 Frazier et al. Oct 2002 B1
6461364 Ginn et al. Oct 2002 B1
6461366 Seguin Oct 2002 B1
6482224 Michler et al. Nov 2002 B1
6488692 Spence et al. Dec 2002 B1
6500115 Krattiger et al. Dec 2002 B2
6506210 Kanner Jan 2003 B1
6508828 Akerfeldt et al. Jan 2003 B1
6511489 Field et al. Jan 2003 B2
6517498 Burbank et al. Feb 2003 B1
6517553 Klein et al. Feb 2003 B2
6517569 Mikus et al. Feb 2003 B2
6533762 Kanner et al. Mar 2003 B2
6533812 Swanson et al. Mar 2003 B2
6537288 Vargas et al. Mar 2003 B2
6547806 Ding Apr 2003 B1
6551319 Lieberman Apr 2003 B2
6551330 Bain et al. Apr 2003 B1
6558399 Isbell et al. May 2003 B1
6562052 Nobles et al. May 2003 B2
6569159 Edwards et al. May 2003 B1
6569173 Blatter et al. May 2003 B1
6569185 Ungs May 2003 B2
6572629 Kalloo et al. Jun 2003 B2
6582452 Coleman et al. Jun 2003 B2
6582482 Gillman et al. Jun 2003 B2
6596012 Akerfeldt et al. Jul 2003 B2
6599303 Peterson et al. Jul 2003 B1
6602263 Swanson et al. Aug 2003 B1
6610072 Christy et al. Aug 2003 B1
6613059 Schaller et al. Sep 2003 B2
6613060 Adams et al. Sep 2003 B2
6616686 Coleman et al. Sep 2003 B2
6623509 Ginn Sep 2003 B2
6623510 Carley et al. Sep 2003 B2
6626918 Ginn et al. Sep 2003 B1
6632237 Ben-David et al. Oct 2003 B2
6632238 Ginn et al. Oct 2003 B2
6634537 Chen Oct 2003 B2
6641592 Sauer et al. Nov 2003 B1
6645205 Ginn Nov 2003 B2
6652538 Kayan et al. Nov 2003 B2
6652556 VanTassel et al. Nov 2003 B1
6663655 Ginn et al. Dec 2003 B2
6669714 Coleman et al. Dec 2003 B2
6676671 Robertson et al. Jan 2004 B2
6676685 Pedros et al. Jan 2004 B2
6679904 Gleeson et al. Jan 2004 B2
6689051 Nakada et al. Feb 2004 B2
6689147 Koster, Jr. Feb 2004 B1
6695867 Ginn et al. Feb 2004 B2
6699256 Logan et al. Mar 2004 B1
6702826 Liddicoat et al. Mar 2004 B2
6712836 Berg et al. Mar 2004 B1
6712837 Akerfeldt et al. Mar 2004 B2
6716228 Tal Apr 2004 B2
6719777 Ginn et al. Apr 2004 B2
6726704 Loshakove et al. Apr 2004 B1
6743195 Zucker Jun 2004 B2
6743243 Roy et al. Jun 2004 B1
6743259 Ginn Jun 2004 B2
6745079 King Jun 2004 B2
6746457 Dana et al. Jun 2004 B2
6749621 Pantages et al. Jun 2004 B2
6749622 McGuckin et al. Jun 2004 B2
6755842 Kanner et al. Jun 2004 B2
6767356 Kanner et al. Jul 2004 B2
6776785 Yencho et al. Aug 2004 B1
6780197 Roe et al. Aug 2004 B2
6786915 Akerfeldt et al. Sep 2004 B2
6790218 Jayaraman Sep 2004 B2
6790220 Morris et al. Sep 2004 B2
6837906 Ginn Jan 2005 B2
6846319 Ginn et al. Jan 2005 B2
6860895 Akerfeldt et al. Mar 2005 B1
6890343 Ginn et al. May 2005 B2
6896687 Dakov May 2005 B2
6896692 Ginn et al. May 2005 B2
6911034 Nobles et al. Jun 2005 B2
6926723 Mulhauser et al. Aug 2005 B1
6926731 Coleman et al. Aug 2005 B2
6939357 Navarro et al. Sep 2005 B2
6942674 Belef et al. Sep 2005 B2
6942691 Chuter Sep 2005 B1
6964668 Modesitt et al. Nov 2005 B2
6969397 Ginn Nov 2005 B2
6989003 Wing et al. Jan 2006 B2
6989016 Tallarida et al. Jan 2006 B2
7001398 Carley et al. Feb 2006 B2
7001400 Modesitt et al. Feb 2006 B1
7008435 Cummins Mar 2006 B2
7008439 Janzen et al. Mar 2006 B1
7029480 Klein et al. Apr 2006 B2
7029481 Burdulis, Jr. et al. Apr 2006 B1
7033379 Peterson Apr 2006 B2
7048747 Arcia et al. May 2006 B2
7060084 Loshakove et al. Jun 2006 B1
7063661 Okada Jun 2006 B2
7063710 Takamoto et al. Jun 2006 B2
7063711 Loshakove et al. Jun 2006 B1
7083635 Ginn Aug 2006 B2
7108709 Cummins Sep 2006 B2
7111768 Cummins et al. Sep 2006 B2
7112225 Ginn Sep 2006 B2
7122002 Okada Oct 2006 B2
7144411 Ginn et al. Dec 2006 B2
7147646 Dana et al. Dec 2006 B2
7160309 Voss Jan 2007 B2
7163551 Anthony et al. Jan 2007 B2
7169158 Sniffin et al. Jan 2007 B2
7169164 Borillo et al. Jan 2007 B2
7179266 Kontos Feb 2007 B2
7211101 Carley et al. May 2007 B2
7229458 Boecker et al. Jun 2007 B2
7235087 Modesitt et al. Jun 2007 B2
7270672 Singer Sep 2007 B1
7311720 Mueller et al. Dec 2007 B2
7316704 Bagaoisan et al. Jan 2008 B2
7326230 Ravikumar Feb 2008 B2
7331979 Khosravi et al. Feb 2008 B2
7335220 Khosravi et al. Feb 2008 B2
7338514 Wahr et al. Mar 2008 B2
D566272 Walburg et al. Apr 2008 S
7361183 Ginn Apr 2008 B2
7361185 O'Malley et al. Apr 2008 B2
7377927 Burdulis, Jr. et al. May 2008 B2
7390328 Modesitt Jun 2008 B2
7393363 Ginn Jul 2008 B2
7396359 Derowe et al. Jul 2008 B1
7431727 Cole et al. Oct 2008 B2
7445626 Songer et al. Nov 2008 B2
7449024 Stafford Nov 2008 B2
7462188 McIntosh Dec 2008 B2
7507200 Okada Mar 2009 B2
7533790 Knodel et al. May 2009 B1
7597706 Kanner et al. Oct 2009 B2
7648493 Forsberg et al. Jan 2010 B2
D611144 Reynolds Mar 2010 S
7727249 Rahmani Jun 2010 B2
7731655 Smith et al. Jun 2010 B2
7749249 Gelbart et al. Jul 2010 B2
7806904 Carley et al. Oct 2010 B2
7819895 Ginn et al. Oct 2010 B2
7901428 Ginn et al. Mar 2011 B2
20010046518 Sawhney Nov 2001 A1
20010053909 Nakada Dec 2001 A1
20020099389 Michler et al. Jul 2002 A1
20020106409 Sawhney et al. Aug 2002 A1
20020188275 McGuckin et al. Dec 2002 A1
20030233095 Urbanski et al. Dec 2003 A1
20040009205 Sawhney Jan 2004 A1
20040093027 Fabisiak et al. May 2004 A1
20040098044 Van de Moer et al. May 2004 A1
20040127940 Ginn et al. Jul 2004 A1
20040143290 Brightbill Jul 2004 A1
20040158127 Okada Aug 2004 A1
20040158287 Cragg et al. Aug 2004 A1
20040167511 Buehlmann et al. Aug 2004 A1
20040191277 Sawhney et al. Sep 2004 A1
20040215232 Belhe et al. Oct 2004 A1
20040267193 Bagaoisan et al. Dec 2004 A1
20040267308 Bagaoisan et al. Dec 2004 A1
20050010248 Lafontaine Jan 2005 A1
20050075665 Brenzel et al. Apr 2005 A1
20050085851 Fiehler et al. Apr 2005 A1
20050085854 Ginn Apr 2005 A1
20050085855 Forsberg Apr 2005 A1
20050121042 Belhe et al. Jun 2005 A1
20050149117 Khosravi et al. Jul 2005 A1
20050177189 Ginn et al. Aug 2005 A1
20050222614 Ginn et al. Oct 2005 A1
20050234396 Forsberg et al. Oct 2005 A1
20050245876 Khosravi et al. Nov 2005 A1
20050256532 Nayak et al. Nov 2005 A1
20050267528 Ginn et al. Dec 2005 A1
20050273137 Ginn Dec 2005 A1
20060034930 Khosravi et al. Feb 2006 A1
20060047313 Khanna et al. Mar 2006 A1
20060089635 Young et al. Apr 2006 A1
20060095029 Young et al. May 2006 A1
20060100664 Pai et al. May 2006 A1
20060106420 Dolan et al. May 2006 A1
20060253037 Ginn et al. Nov 2006 A1
20060253072 Pai et al. Nov 2006 A1
20060259049 Harada et al. Nov 2006 A1
20070049967 Sibbitt, Jr. et al. Mar 2007 A1
20070049968 Sibbitt. Jr. et al. Mar 2007 A1
20070060895 Sibbitt, Jr. et al. Mar 2007 A1
20070060950 Khosravi et al. Mar 2007 A1
20070083231 Lee Apr 2007 A1
20070123817 Khosravi et al. May 2007 A1
20070198058 Gelbart et al. Aug 2007 A1
20070203506 Sibbitt, Jr. et al. Aug 2007 A1
20080009794 Bagaoisan et al. Jan 2008 A1
20080045979 Ma Feb 2008 A1
20080065151 Ginn Mar 2008 A1
20080065152 Carley Mar 2008 A1
20080287967 Andreas et al. Nov 2008 A1
20090088794 LaFontaine Apr 2009 A1
20100130965 Sibbitt, Jr. et al. May 2010 A1
20100234884 Lafontaine et al. Sep 2010 A1
Foreign Referenced Citations (21)
Number Date Country
2768324 Mar 1999 FR
WO 02062234 Aug 2002 WO
WO 03094748 Nov 2003 WO
WO 2005000126 Jan 2005 WO
WO 2005041782 May 2005 WO
WO 2005063129 Jul 2005 WO
WO 2005092204 Oct 2005 WO
WO 2005112782 Dec 2005 WO
WO 2006026116 Mar 2006 WO
WO 2006052611 May 2006 WO
WO 2006052612 May 2006 WO
WO 2006078578 Jul 2006 WO
WO 2006115901 Nov 2006 WO
WO 2006115904 Nov 2006 WO
WO 2006118877 Nov 2006 WO
WO 2007025014 Mar 2007 WO
WO 2007025017 Mar 2007 WO
WO 2007025018 Mar 2007 WO
WO 2007025019 Mar 2007 WO
WO 2007081836 Jul 2007 WO
WO 2010031050 Mar 2010 WO
Related Publications (1)
Number Date Country
20090254119 A1 Oct 2009 US
Continuations (1)
Number Date Country
Parent 11316775 Dec 2005 US
Child 12365397 US